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Abstract
Background: In South America, the history of human genetics is extensive and its beginnings go back to the onset
of the twentieth century. In Ecuador, the historical record of human genetics and genomics research is limited. In
this context, our work analyzes the current status and historical panorama of these fields, based on bibliographic
searches in Scopus, Google Scholar, PubMed, and Web of Science.
Results: Our results determined that the oldest paper in human genetics coauthored by an Ecuadorian institution
originates from the Central University of Ecuador in 1978. From a historical standpoint, the number of articles has
increased since the 1990s. This growth has intensified and it is reflected in 137 manuscripts recorded from 2010 to
2019. Areas such as human population genetics, phylogeography, and forensic sciences are the core of genetics
and genomics-associated research in Ecuador. Important advances have been made in the understanding of the
bases of cancer, some genetic diseases, and congenital disorders. Fields such as pharmacogenetics and
pharmacogenomics have begun to be explored during the last years.
Conclusions: This work paints a comprehensive picture and provides additional insights into the future panorama
of human genetic and genomic research in Ecuador as an example of an emerging, resource-limited country with
interesting phylogeographic characteristics and public health implications.
Keywords: Human genetics, Human genomics, South America, Ecuador, PubMed, Scopus, Google Scholar, Web of
Science, Database search
Background
In recent years, the understanding of the genetic bases of
complex diseases such as heart diseases, diabetes, and cere-
brovascular disorders has notably grown thanks to human
genetics and human genomics research worldwide [1–6].
Whereas the history of human genetics investigations in
Latin America is broad, the historical record of human ge-
nomics research is more limited and recent. The beginning
of medical genetics in the region was marked by Luis
Morquio, who worked on mucopolysaccharidosis in 1929,
in Uruguay [7]. From the Ecuadorian standpoint in human
and medical genetics, three facts are important to mention:
first, the oldest scientific document about human genetics
in Ecuador was the book “La genética y el hombre”
(Genetics and Man) published by Robert Hoffstetter in 1947
[8]. Second, the Ecuadorian Society of Human Genetics
(SEGH) was legally constituted in 1994 [9]. Third, the Gen-
omics and Genetics Network [“Red de Genética y Genó-
mica” (ReGG)] in Ecuador was legally established in 2018.
Recent efforts, such as the book “Genética en el
Ecuador: 30 años” (Genetics in Ecuador: 30 years), pub-
lished in 2016, has collected historical data of scientific
manuscripts related to medical genetics in Ecuador [9].
In this document, the authors identified a total of 354
books and 259 scientific articles of medical genetics–as-
sociated works from 1984 to 2016 present in different
databases [9]. Even though this work gives us an overall
insight into the history and current state of medical gen-
etics, many gaps still remain in human genetics and gen-
omics research in Ecuador. Data such as the beginnings
and the trends of research in human genetics and gen-
omics in Ecuador, the distribution of human genetic and
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genomic research across different associated medical
areas, plus the quality and impact of the Ecuadorian
scientific articles published in different peer-reviewed
journals are still unknown and this phenomenon can be
attributed to the limited access to the historical record
and the lack of local databases in Ecuador.
To examine the historical context and current landscape
of human genetics and human genomics in Ecuador, we
performed a detailed analysis of research in these areas
based on bibliographic searches in PubMed, Scopus, Goo-
gle Scholar, and Web of Science. In this context, we scored
scientific articles published in peer-reviewed journals and
co-authored by investigators from Ecuadorian institutions.
The aim of this paper is to establish the current status and
historical research trends of human genetics and human
genomics in Ecuador. Furthermore, our study attempts to
analyze research across different health and medical areas,
and human diseases so it may enable to precisely deter-
mine how the research in human genetics and human
genomics is distributed and concentrated within the health
care context of Ecuador as an example of an emerging,
resource-limited country.
Results
Relevant articles identified in Scopus, PubMed, Google
Scholar, and Web of Science
The keywords “Human Genetic Ecuador” and “Human
Genomic Ecuador” in all search engines produced initially
40,506 hits. After the scrutinization process, the primary
bibliographic searches for both “Human genetic Ecuador”
and “Human genomic Ecuador” in Google Scholar,
PubMed, Scopus, and Web of Science provided 38,890;
553; 386; and 677 results, respectively (Table 1). These
data sets were scrutinized based on two principles: first,
their relationship to human genetics and genomics and
second, articles published by authors belonging to Ecua-
dorian institutions. In this context, PubMed provided a
total number of 133 articles of interest, which were re-
trieved from 553 records identified in the primary search
(Table 1), whereas in Web of Science, 90 manuscripts
were recovered from 677 records. Additionally, the search
in Scopus resulted in 120 publications of interest retrieved
from 386 publications whereas in Google Scholar, the
research produced 275 relevant records obtained from 38,
890 publications in the primary search. Based on its search
efficiency of 31.08%, Scopus was the most useful search
engine in terms of yield to seek out publications in both
fields, human genetics, and human genomics, in Ecuador
(Table 1). In contrast, Google Scholar with a search effi-
ciency of 0.71% was the least effective in terms of pertin-
ent results per analyzed data quantity which could be
attributed to the search methodology (search per year). It
is worth mentioning that there were several common arti-
cles for at least two databases found as either “Human
Genetic Ecuador” or “Human Genomic Ecuador,” depend-
ing on the search engine. This trend may be attributed to
the overlap of field of study within these biomedical areas
so that it was necessary to build up a record of unique
articles for subsequent analysis.
Survey of human genetics and human genomics in
Ecuador
Our final definitive record, which consisted of 209 unique
articles of interest retrieved from the three different search
engines, is summarized in Fig. 1. Our bibliographic register
includes 152 primary research articles, 14 announcements
of population data and short population reports, 13
reviews, 10 short communications, 6 letters to the editor, 4
Table 1 Number of articles analyzed and number of relevant manuscripts recorded in PubMed, Scopus, Google Scholar and Web of
Science
Database Analysis and processing
of data
Type of search Total number
of articles
Search efficiency*
(%)
“Human genetic
Ecuador”
“Human genomic
Ecuador”
PubMed Articles analyzed 295 258 553 24.05
Relevant articles in human
genetics/human genomics
52 81 133
Scopus Articles analyzed 349 37 386 31.08
Relevant articles in human
genetics/human genomics
103 17 120
Web of Science Articles analyzed 643 34 677 13.30
Relevant articles in human
genetics/human genomics
81 9 90
Google Scholar Articles analyzed 27,557 11,333 38,890 0.71
Relevant articles in human
genetics/human genomics
157 118 275
*Search efficiency of each database is the ratio between number of interest articles and number of analyzed articles. Subsequently, these proportions were
transformed to percentage in order to standardize the data
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country reports, 4 software reviews and sequence registers,
3 case reports, 2 conference reports, and 1 opinion article.
Subsequently, these manuscripts were reclassified accord-
ing to their potential direct relationship to human genetics,
human genomics, or both in order to normalize all data.
Our research shows (Fig. 2) that 183 articles representing
87% of all publications fall into human genetics research.
In contrast, only 16 articles, 8% of the whole set, include
human genetics research using genomic techniques such as
whole genome sequencing, exome sequencing, transcrip-
tome sequencing, microarrays, etc. Finally, only 10 articles,
or 5 % of the entire record, are directly related to human
genomics research in Ecuador. This situation reflects that
the current research technologies, especially those associ-
ated to human genomics, have been largely underutilized
in an emerging country like Ecuador. This latter
phenomenon has been attributed to the limited funding,
the elevated cost of setting up and supporting a research fa-
cility, the absence of experienced personnel, the restricted
availability of tools for data use and analysis, the lack of a
well-established regulatory frame, and even a restricted ac-
cess to updated proper literature (Helmy, Awad, & Mosa,
2016). However, this Ecuadorian reality opens new future
lines of research not only in this relatively unexplored area
Fig. 1 Ecuadorian scientific output associated with human genetics and human genomics classified according to the types of scientific articles
Fig. 2 Percentage of articles, which were retrieved from Scopus, PubMed, Google Scholar, and Web of Science, classified as human genetics,
human genomics, or both in Ecuador
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in the country but also in associated biomedical and other
fields.
Historical outlook of human genetics and human
genomics research
In Ecuador, the beginning of research in human genetics
and genomics is relatively recent compared to other
countries in South America [7]. In the region, the onset of
clinical genetics can be traced back to 1929 with Luis
Morquio, who worked on mucopolysaccharidosis in
Uruguay [7, 10]. In Argentina, Sáez and Etcheverry
worked on cytogenetics in 1934 and on the rhesus blood
group system in 1945, respectively [7]. In Ecuador, Leone
and Paz-y-Miño (2016) showed that the oldest scientific
article is “Introducción a la ecología médica ecuatoriana I
parte” (“Introduction to Ecuadorian medical ecology–part
I”), published in the Ecuadorian Cultural Center’s bulletin
(Boletín Científico Casa de la Cultura Ecuatoriana) in
1984 [9]. However, our own survey determined that the
oldest scientific article found in Scopus and Google
Scholar was “The multinational Andean genetic and
health program: II. Disease and disability among the Ay-
mara” published in 1978 and whose authors include Biffret
Díaz, Daniel Gallegos (affiliated to the Central University
of Ecuador), Federico Murillo, Edmundo Covarrubias,
Thusnelda Covarrubias, Roberto Rona, William Weidman,
Francisco Rothhammer, and William J. Schull [11].
Recent studies have shown that scientific publications in
conventional peer-reviewed journals have significantly in-
creased worldwide [12]. Countries with an expanding
economy have ramped up their production of science,
innovation, and technology [13]. Figure 3 reports that the
number of publications in both human genetics and hu-
man genomics has increased during the last couple of de-
cades in Ecuador. From a historical standpoint, our survey
determined 24 articles published from 1978 to 1999, 48
articles published from 2000 to 2009, and the number of
publications from 2010 through June 2019 is 137. In this
context, the growth rate of human genetic research is
more noticeable after the 1990s because previous numbers
are relatively inconsequential. This latter situation may be
attributed to the fact that the databases analyzed do not
include certain Latin American journals and Ecuadorian
journals. Since 2010, there has been a pronounced in-
crease in the number of scientific publications of both
fields in conventional peer-reviewed journals compared to
previous decades. SCImago Journal and Country Rank
(SJR), which is an evaluation portal for journals and coun-
tries based on data contained in the Scopus database since
1996, support our inferences about Ecuador as a promis-
ing science generator by placing Ecuador in 87th place
among 239 countries, in regard to research in clinical gen-
etics and medicine, in 2016 (SCImago Journal & Country
Rank, 2019a). Additionally, this is consistent with a
very recent analysis which found that research prod-
uctivity in Ecuador increased by more than five-fold
from 2006 to 2015 across the ten most represented
scientific fields in the country [13].
International cooperation in research has played an
important role in Ecuadorian scientific output associated
to human genetics and human genomics. The emerging
phenomenon of global cooperation in research with in-
dustrialized countries has been manifested through large
increases in co-publication between Europe and other
Fig. 3 Trendline of Ecuadorian scientific production in human genetics and human genomics since 1978 based on data retrieved from PubMed,
Scopus, Google Scholar, and Web of Science
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regions [14]. In Ecuador, this cooperation in science can
largely be perceived as a national, regional, and global
phenomenon. Figure 4 shows that most of Ecuadorian
scientific output (68% of the whole record) associated
with human genetics and human genomics has been
achieved through joint work involving both Ecuadorian
and foreign institutions. Furthermore, Ecuadorian scien-
tific output developed thanks to cooperation among
Ecuadorian institutions such as public and private uni-
versities and hospitals which represents 20% of the
whole record, while 12% of the studies and publications
retrieved from the literature has been carried out solely
by individual Ecuadorian institutions with great efforts.
Global collaboration is growing as a part of all scientific
cooperation, as manifested by co-authorships of articles
published in peer-reviewed journals worldwide [15]. From
the Ecuadorian standpoint, such partnerships allow the in-
creasing costs of research infrastructure and technological
facilities to be shared. In addition, this cooperation must be
seen as a link which enables Ecuadorian researchers to
establish new collaborative projects between different
scientific fields. Partnerships in research allow researchers
and scholars to become familiar with other research sys-
tems and funding opportunities. Finally, this cooperative
approach is becoming a tool to draw attention to young
and promising Ecuadorian scientists. These realizations are
reflected in the recently reported finding that over 80% of
Ecuadorian publications in the last decade involve
international collaboration [16]. In this connection, it is
instructive to compare this trend with the current state of
genomic medicine research in neighboring Colombia,
where international collaboration is helping local
professionals to develop technical, medical, and scien-
tific expertise based on standards of developed coun-
tries [17].
Scientific fields associated to human genetics and human
genomics research
In Ecuador, human genetics and genomics research has
focused on different health and medical areas and many
human diseases. Figure 5 summarizes the classification
of articles according to the corresponding medical, sci-
entific, or technological area. In spite of the wide range
of associated research fields, our study identified the
following three dominant scientific and medical areas in
which human genetics and genomics research has
intensified over the last decades:
1. Population studies, human phylogeography, and
forensic science.
2. Genetic diseases and congenital disorders.
3. Cancer and solid tumors.
First, our survey determined that 74 articles, representing
35% of our whole Ecuadorian dataset, are closely related to
human population genetics, as well as phylogeography,
which describe the human historical processes such as
population expansion and migration that influence spatial
distributions of contemporary human communities (Fig. 5).
Due to overlapping research approaches, this category also
covers forensic genetics, including the study of genetic
markers which are specific to ethnic subgroups of the Ecua-
dorian population and can be used for forensic purposes,
such as genetic typing of samples from criminal cases, the
Fig. 4 Classification of Ecuadorian scientific output associated to human genetics and genomics based on international or national co-authorship
of articles published in peer-reviewed journals
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research of familial relatedness, and the identification of
missing persons or victims of disasters [18].
Second, 14% of the whole bibliographic dataset,
which represents 30 articles, refers directly to genetic
diseases and congenital and rare disorders (Fig. 5).
According to the World Health Organization (WHO),
congenital disorders annually cause around 303,000
deaths of newborns within the first 4 weeks of birth
in the worldwide [19].
Third, 29 publications related to genetics of cancer rep-
resent 14% of all documents retrieved from the three data-
bases (Fig. 5). The number of deaths attributed to cancer
in the world increased to 8.9 million in 2016 [20]. Accord-
ing to the WHO, the number of new cancer cases is
assumed to increase by around 70% over the next 20 years
[21]. In this context, all Ecuadorian publications have con-
tributed notable efforts in understanding the molecular
bases of cancer over the last few decades [22–25].
It is worth mentioning that relatively novel genetic
and genomic research areas are being explored in
Ecuador. Our study identified eight articles, i.e., 4% of
the whole register, which are directly related to pharma-
cogenetics and pharmacogenomics (Fig. 5). In Latin
America, the development of these fields faces many
challenges such as the lack of available clinical laborator-
ies and trained personnel, the low investment in re-
search, and ethical aspects [17, 26]. In spite of these
adverse circumstances, these areas have shown expand-
ing trends in health and medical sciences so both
efforts and resources should be committed to the devel-
opment of these fields to guarantee the success of drug
development and therapeutics for the Ecuadorian popu-
lation [27, 28].
Discussion
Current research status of human genetics and human
genomics in Ecuador
In Latin America, a meaningful increase in both research
spending and scientific output has been driven by the
dynamic and emerging economies in the region. Brazil
dominates as a major player in regional science, whereas
Chile shows great advances in patents [29]. Ecuador in
terms of medical research including clinical genetics was
placed twelfth among 36 countries and dependent terri-
tories in Latin America, based on the number of articles
published from 1996 through 2018 [30]. Furthermore,
both productivity and impact of today’s most active re-
search areas, as cataloged in Scopus, are on the ascen-
dance in Ecuador over the last decade [13, 16]. All of
this reflects a promising future of Ecuador as an emer-
ging producer of science in the region [13, 16, 27].
Although the research output in human genetics and
human genomics in the region has significantly in-
creased during the last decades, a number of problems
still remain. In South America, research impact and
quality have not kept pace with growing scientific pro-
duction so that the region’s research articles still struggle
to capture citations from the rest of the world [31, 32].
Second, based on the number of articles published from
1996 through 2018, Ecuador continues to occupy one of
the last places with respect to medical research including
clinical genetics in 2018, more specifically 8th place
among 10 countries in South America [30]. Therefore, it
is necessary to develop educational and funding strat-
egies at all organizational levels in order to promote
high-quality research in the country, including in-human
genetics and genomics along with cognate medical areas.
Fig. 5 Percentage of articles in human genetics and human genomics associated with different health and medical specialties and human
diseases in Ecuador
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Future perspectives
From the genetic standpoint, the ethnic background, as
well as ancestry, may have relevance for the understanding
of epidemiology and treatment of many disorders affecting
Ecuadorian populations [33]. According to the last national
census of 2010, the size of the Ecuadorian population was
14,483,499 inhabitants of whom 71.9% self-identified as
Mestizos (people of mixed European and Amerindian
ancestry); 7.4% as Montubios (half-caste population, of
indigenous origin, and inhabiting certain zones in the
Ecuadorian coast region); 7.2% as Afro-descendants (Afri-
can ancestry); 7% as Amerindians; and 6.1% as Caucasians
(mostly European ancestry) [34]. Gonzales and López-
Pulles (2010) segregated the Ecuadorian population in
three major ethnic groups: Mestizos, Amerindians, and
Afro-Americans. This ethnic diversity, which has emerged
due to ethnically intermixing processes, such as different
waves of migration and colonization in history, has built
up a particular genetic structure of the Ecuadorian popula-
tion across the country’s whole territory [35]. As far as en-
suring participant safety and research quality, this ethnic
complexity in the population makes Ecuador a key country
to carry out clinical studies in which the incidence, as well
as the prevalence of particular diseases, differs among
ethnic subgroups.
Despite the high similarity between individuals’ genetic
material, several variants in DNA sequences such as nu-
cleotide polymorphisms, deletions, insertions, and tandem
repeats exist across different human populations [36]. Even
though there are extrinsic elements such as several demo-
graphic and environmental factors which can influence
drug response variability, these differences can also be ex-
plained through intrinsic aspects such as ethnicity, ancestry,
and differences in the expression of drug-metabolizing en-
zymes or drug transporters, as well as in the expression of
drug targets, due to the large genetic variability within a
particular population [37]. In this context, novel fields such
as pharmacogenetics and pharmacogenomics have opened
innovative therapeutic methodologies through the use of
current genomics advances such as next-generation
sequencing, whole-exome and whole-genome-association
studies, preferably including diverse and under-represented
individuals, which have led to the understanding of the
genomic basis and the genetic etiologies of complex
diseases [38]. This latter approach based on identifying
pharmacogenetic biomarkers together with the study of
pharmacogenetic allele frequencies in different ethnic
groups will allow to personalize drug prescription, drug
dosing, prevent adverse side effects, and avoid unsuccessful
therapies or over-prescription, plus leading to understand
the impact of variation in the risk for drug-specific depend-
ence and approaching the molecular and gene-expression
mechanisms involved [39]. In this context, precision medi-
cine defined as patient-targeting treatments encourages the
use of novel diagnostic and therapeutic methodologies that
are personalized to satisfy the patient’s individual needs
based on phenotype, pharmacogenetic markers, and even
psychosocial aspects [40].
In emerging countries such as Ecuador, the development
of fields such as pharmacogenetics and pharmacogenomics
has been restricted by scarce research funding, limited
knowledge about population gene structure, lack of accre-
dited cell line collections, the lack of highly specialized
scientific and technological public or private institutions,
the lack of research and working networks in human gen-
omic medicine, and persistent uncertainty about economic
and health care benefits, i.e., issues affecting most resource-
limited countries [41]. The future outlook for the Ecuador-
ian health care system should envisage genotype-based
therapies based on cost efficiency thanks to rational treat-
ment and the improvement of patients’ quality of life. In
this context, future research expectations in human genet-
ics and human genomics should be focused on pharmaco-
genetics, pharmacogenomics and associated fields, and
enabling technologies such as cell sorting, proteomics,
metabolomics, and epigenetics in order to promote person-
alized medicine in diagnosis, drug development, and ther-
apy. Their implementation is a complex political, social,
and ethical process in which all stakeholders such as health
care institutions, universities, public and private research
centers, health care providers, and decision-makers are
responsible for carrying Ecuadorian medicine into the
genomic era in spite of the scarce resources, in accordance
with a “mid-stream” or “fast-second winner” model of
innovation [27]. This hopeful model allows a developing
country to learn from other countries’ mistakes upstream
in basic research and work its way from multiple entry
points based on the local characteristics towards trans-
lational and clinical implementation commensurate to the
country’s limited resources [27, 41]
Conclusions
Research in human genetics and genomics in Ecuador
emerged relatively late compared to other South Ameri-
can countries in the 20th century. In Ecuador, the oldest
documented record in human genetics can be dated
back as far as 1947, whereas the oldest article published
in a peer-reviewed journal is traced back to 1978. A sig-
nificant rise in human genetics research output can be
noticed since the 1990s and its growth rate has substan-
tially increased since 2007. In contrast, recent efforts in
human genomics have resulted in limited numbers of
publications included in the databases analyzed.
Scientific areas such as human population genetics,
phylogeography, and forensic sciences are hot topics of
gene and genome-related studies during the last decades.
Furthermore, significant advances have been made in
terms of understanding the molecular and genetic bases
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of some types of cancer, some genetic diseases, and
congenital disorders. Additionally, novel fields such as
pharmacogenetics and pharmacogenomics have started
being explored lately.
In spite of this promising reality, the quality of the
publications and the impact of the research are critical
so they must be evaluated in depth and strengthened in
Ecuador. In this context, the current survey of human
genetics and genomics research in Ecuador is encour-
aging and indicates that the Ecuadorian research in the
mentioned fields is poised to expand further to contri-
bute to the country’s needs as well as Latin America’s
and perhaps the world’s knowledge base.
A plurality of Ecuadorian stakeholders including, most
notably, academic researchers and clinical practitioners
have charted the course of the research in human genetics
and human genomics. The current necessities and gaps
can be filled through strengthening national and inter-
national collaborations and partnerships in which the cost
of the infrastructure and technological facilities can be
shared and the researchers and institutions can look for
joint and novel projects. The promotion of collaboration
networks is a great opportunity not only for the Ecuador-
ian research establishment to get to know other research
systems and funding opportunities but also to recruit
young and promising Ecuadorian scientists.
Methods
Retrieving articles from PubMed, Google Scholar, Scopus,
and Web of Science
Our literature survey included primary research articles,
announcements of population data, short population re-
ports, reviews, short communications, letters to the editor,
country reports, software reviews, case reports, conference
reports, opinion articles, and sequence registers in PubMed,
Google Scholar, Scopus, and Web of Science through June
2019. The keywords were “Human Genetic Ecuador” and
“Human Genomic Ecuador” and the searches were done
via adjusting “custom range” to limit the searches per year
and “sort by relevance” that was the criterion employed for
“sorting order.”
Processing and categorizing articles
1. Article types published in peer-reviewed journals.
The publications in the final record were categorized
depending on article type based on the criteria of each
peer-reviewed journal. The following classes were
considered:
 Research article including novel and original
primary research works.
 Announcement of population data and short population
report, articles aimed at the publication of population
data of human polymorphisms, and manuscripts
focusing on immunogenomic population data.
 Review summarizing insights or findings in fields
associated to human genetics and genomics.
 Short communication, short papers addressing
controversial ideas and novel findings and do not
meet the “research article standards.”
 Letter to the editor focusing on analysis of
previously published articles or short articles of
broad interest for the journal’s readers.
 Country report, short announcements of research
results related to status and the historical perspective
of a medical or scientific field in a country.
 Software review and sequence register, reports about
novel bioinformatic tools or available software and
reports of nucleotide sequence data.
 Case report, well-documented medical and clinical
reports of cases including disease, symptoms, signs,
diagnosis, and treatment in individual patients.
 Conference report and opinion article not only show
key findings and conclusions presented and
discussed at conferences but also include opinion
manuscripts about the current high-impact findings
in the relevant scientific area.
2. The direct relationship between publications and
human genetics, human genomics, or both fields
Subsequently, by analyzing the title, abstract, and its
keywords, each article was classified according to its re-
search relationship with human genetics, human genom-
ics, or both fields. The term “relationship” puts emphasis
on the research approach or aim, the research method-
ology and technology (such as whole genome sequen-
cing, whole exome sequencing, etc.) used to carry out
the experimental study.
3. Research encompassing interinstitutional
cooperation
To understand the role that the research cooperation
between Ecuadorian institutions and foreign institutions
has played in the development and growth of human
genetic and genomic research, the articles were classified
in accordance with the affiliations of all authors.
 “Studies carried out in cooperation between
Ecuadorian institutions” involves publications whose
authors’ affiliations showed more than one
Ecuadorian institution.
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 “Studies carried out in cooperation with foreign
institutions” include articles whose authors’
affiliations consisted of both Ecuadorian and foreign
institutions.
 “Studies carried out by individual Ecuadorian
institutions” includes papers published by
researchers affiliated to a single research Ecuadorian
institution.
4. The associated scientific or medical field
For a better understanding of the current state of hu-
man genetics and human genomics research in Ecuador,
all articles were grouped according to their relationship
to other scientific fields, medical areas, or human di-
seases. Our survey considered the following categories
which were based on some topics covered during confer-
ences and scientific congresses associated to human and
medical genetics [42, 43]:
 Cancer and genetics of solid tumors.
 Genetics of ophthalmologic diseases.
 Genetic diseases, congenital, and rare disorders.
 Genetic engineering and bioinformatic tools.
 Genetics of other complex or multifactorial
disorders.
 Genotoxicology.
 Health genetics and genomics, and genetic services.
 Immunogenetics and immunogenomics.
 Metabolic and cardiovascular diseases.
 Neurodevelopmental disorders.
 Human genetic variations associated with parasitic,
fungal, bacterial, and viral infections
 Pharmacogenetics and pharmacogenomics.
 Population studies, human phylogeography, and
forensic sciences.
 Prenatal diagnosis, genetic counseling, disorders of
pregnancy, and menopause.
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